診療ガイドライン作成にあたって、パネリストには具体的にどのような質問をすべきなのだろうか。

IOMの信頼できる診療ガイドライン（Clinical practice guidelines we can trust）に記載されている、「ワークショップの課題とパネリストへの質問」（Appendix B）で、2010年1月のWashington, DCで開催されたワークショップで利用されたものが以下です（フリーで公開されているものなので、紹介します）。

What do you believe are the biggest challenges clinical practice guidelines developers/users face today? For example:

• What do you do when the scientific evidence is absent or poor?
• How do you reconcile disagreements in evidence interpretation among guidelines?
• How do guidelines accommodate subgroups (e.g., older populations or persons with multimorbidities) whose treatment outcomes may differ from the average patient?
• Are there other challenges you believe are important?

What topics and/or processes do you think the committee should consider in deriving quality standards for clinical practice guidelines? For example:

• What should the composition of CPG development panels,in particular the balance of methodologists, topical experts, and consumers, look like?
• What methods might be developed for determining which recommendations among those in a guideline should be applied to quality measures or electronic medical record decision prompts?
• Is there an available assessment tool that adequately rates both the level of the scientific evidence and strength of clinical recommendations that should be used as standard practice in guideline development?
• What administrative (e.g., accreditation) or legal approaches might improve the quality of clinical practice guidelines?
• What explicit approaches might harmonize guideline developers and increase guidelines convergence?
• What types of strategies might promote greater use of guidelines?
• Are there other characteristics of guideline standards you think are important for the committee to consider?

上記を翻訳したものが、こちらです.（WORD、PDF）。